ONCSM.E — Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapFalling Star

Market Cap
TRY2.11bn
Enterprise Value
TRY2.11bn
Revenue
TRY374.49m

Annual cashflow statement for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	18.7	71.7	-20.8	-115	-59.2
Depreciation
Deferred Taxes
Non-Cash Items	5.59	5.22	-2.72	72.3	60.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-10.3	-33	25.1	-75.1	-0.123
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	19.4	51.7	45	-82.5	61.6
Capital Expenditures	-16.3	-13	-26	-45.6	-23.8
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.078	-24.8	-1.05	13.9	-0.46
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities	-16.2	-37.8	-27.1	-31.7	-24.2
Financing Cash Flow Items	-4.43	-2.31	-1.47	125	-34.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1.63	-16.6	-14.3	171	-77.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1.55	-2.65	3.63	56.7	-39.9